A critical discovery in cancer research is emerging with the use of nanobodies to reactivate dysfunctional p53. This crucial tumor inhibitor protein is frequently inactivated in various kinds of malignancies, causing https://zbookmarkhub.com/story22119848/nanobodies-reactivate-tumor-suppressor-p53-the-new-approach-for-cancer-management